Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study.

Xiao HouLi TianLei ZhouXinhua JiaLi KongYitao XueHao HaoXianqing MengFeihu ZhangXiaobin Dong

Published in: Virology journal (2021)

Adjuvant therapy with IVIG did not improve in-hospital mortality rates or the need for mechanical ventilation in severe COVID-19 patients. Our study does not support the use of immunoglobulin in patients with severe COVID-19 patients.

Keyphrases

mechanical ventilation
sars cov
early onset
acute respiratory distress syndrome
coronavirus disease
intensive care unit
high dose
drug induced
respiratory failure